GVAG
BDRX

Great Valley Advisor Group’s Biodexa Pharmaceuticals BDRX Stock Holding History

Great Valley Advisor Group’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– -$27K – 680
2022
Q2 		– Hold
0
– – – 658